<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>AMPT</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/AMPT">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">AMPT</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Alpha-methyl-<i>p</i>-tyrosine (AMPT)</b> is a tyrosine hydroxylase enzyme inhibitor. Alpha-methyl-<i>p</i>-tyrosine (AMPT) is a non-endogenous drug involved in the catecholamine biosynthetic pathway.<span class="mw-ref" id="cite_ref-nestler_1-0"><a href="#cite_note-nestler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> AMPT inhibits tyrosine hydroxylase whose enzymatic activity is regulated through the phosphorylation of different serine residue regulatory domain sites.<span class="mw-ref" id="cite_ref-nestler_1-1"><a href="#cite_note-nestler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Catecholamine biosynthesis starts with dietary tyrosine, which is hydroxylated by the enzyme tyrosine hydroxylase. It is hypothesized that AMPT competes with tyrosine at the tyrosine-binding site, causing inhibition of tyrosine hydroxylase.<span class="mw-ref" id="cite_ref-ankenman_2-0"><a href="#cite_note-ankenman-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></p>

<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>AMPT</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/AMPT-2d-skeletal.png" tppabs="https://ptable.com/wiki/compounds/I/m/AMPT-2d-skeletal.png" data-file-width="1611" data-file-height="646" data-file-type="bitmap" height="60" width="150"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">2-amino-3-(4-hydroxyphenyl)-2-methylpropanoic acid</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=658-48-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=658-48-0'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=658-48-0" class="external text external">658-48-0</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/3125  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/3125'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/3125" class="external text external">3125</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5094  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5094'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=5094" class="external text external">5094</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.3013.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.3013.html'" tppabs="http://www.chemspider.com/Chemical-Structure.3013.html" class="external text external">3013</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=X88TTO174Z  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=X88TTO174Z'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=X88TTO174Z" class="external text external">X88TTO174Z</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.010.477  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.010.477'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.010.477" class="external text external">100.010.477</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>10</sub><span>H</span><sub>13</sub><span>N</span><span>O</span><sub>3</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td><span class="nowrap">195.218</span><span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%28N%29%28Cc1ccc%28O%29cc1%29C  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%28N%29%28Cc1ccc%28O%29cc1%29C'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28O%29C%28N%29%28Cc1ccc%28O%29cc1%29C" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(O)C(N)(Cc1ccc(O)cc1)C</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C10H13NO3/c1-10(11,9(13)14)6-7-2-4-8(12)5-3-7/h2-5,12H,6,11H2,1H3,(H,13,14)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:NHTGHBARYWONDQ-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=447384724&page2=AMPT  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=447384724&page2=AMPT'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=447384724&page2=AMPT" class="external text external">(verify)</a></span></span></td></tr></tbody></table>
<p>It has been used in the treatment of pheochromocytoma.<span class="mw-ref" id="cite_ref-ankenman_2-1"><a href="#cite_note-ankenman-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span>  It has been demonstrated to inhibit the production of melanin.<span class="mw-ref" id="cite_ref-3"><a href="#cite_note-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    


    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Effect_on_catecholamine_biosynthesis">Effect on catecholamine biosynthesis</h3></summary>
    

<p>AMPT inhibits catecholamine biosynthesis at the first step—the hydroxylation of tyrosine.<span class="mw-ref" id="cite_ref-brogden_4-0"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Reduction in catecholamines and their metabolites (normetanephrine, metanephrine, and 4-hydroxy-3-methoxymandelic acid) result from the inhibition of tyrosine using AMPT.<span class="mw-ref" id="cite_ref-brogden_4-1"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> AMPT doses of 600 to 4,000<span>&nbsp;</span>mg per day cause a 20 to 79 percent reduction in total catecholamines in Pheochromocytoma patients.<span class="mw-ref" id="cite_ref-brogden_4-2"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Increase in dosage increases the magnitude of catecholamine synthesis inhibition.<span class="mw-ref" id="cite_ref-brogden_4-3"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> This increasing inhibitory effect is seen in dosages up to 1500<span>&nbsp;</span>mg per day; at higher doses, the inhibitory effect of AMPT decreases.<span class="mw-ref" id="cite_ref-brogden_4-4"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> The maximum effect of orally administered AMPT occurs 48 to 72<span>&nbsp;</span>hours after administration of the drug.<span class="mw-ref" id="cite_ref-engelman_1968_5-0"><a href="#cite_note-engelman_1968-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> Catecholamine production levels return to normal 72 to 96 hours after administration of the drug ceases.<span class="mw-ref" id="cite_ref-engelman_6-0"><a href="#cite_note-engelman-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Dosages as low as 300<span>&nbsp;</span>mg per day have been found to have an effect on catecholamine production, which can be measured through urinary excretion analysis and cerebral spinal fluid assays.<span class="mw-ref" id="cite_ref-brogden_4-5"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span>    
AMPT is successful at inhibiting catecholamine production in humans whether the rate of synthesis is high, as in pheochromocytoma, or normal as in patients with hypertension.<span class="mw-ref" id="cite_ref-engelman_1968_5-1"><a href="#cite_note-engelman_1968-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Effect_on_blood_pressure">Effect on blood pressure</h3></summary>
    

<p>Pheochromocytoma patients exhibited a drop in blood pressure when taking AMPT.<span class="mw-ref" id="cite_ref-engelman_6-1"><a href="#cite_note-engelman-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> AMPT had no effect in patients with hypertension (high blood pressure).<span class="mw-ref" id="cite_ref-engelman_6-2"><a href="#cite_note-engelman-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacokinetics">Pharmacokinetics</h2></summary>
    
<p><i><b>Absorption</b></i> 
AMPT is minimally metabolized by the body and absorbed well after oral ingestion making its bioavailability high.<span class="mw-ref" id="cite_ref-brogden_4-6"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Single-dose studies have shown that a 1,000<span>&nbsp;</span>mg dose results in AMPT levels in the plasma of 12-14<span>&nbsp;</span>µg/mL after 1 to 3 hours of ingestion.<span class="mw-ref" id="cite_ref-engelman_6-3"><a href="#cite_note-engelman-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Maintenance-dose studies have shown that absorption of AMPT is overall the same in all individuals taking doses in the range of 300-4,000<span>&nbsp;</span>mg per day.<span class="mw-ref" id="cite_ref-engelman_6-4"><a href="#cite_note-engelman-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span></p>

<p><i><b>Half-life</b></i></p>

<p>The half-life of AMPT in normal patients is 3.4 to 3.7 hours.<span class="mw-ref" id="cite_ref-brogden_4-7"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> In amphetamine addicts the half-life is 7.2 hours.<span class="mw-ref" id="cite_ref-brogden_4-8"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p><i><b>Elimination</b></i></p>

<p>Small amounts of metabolites (alpha-methyldopa and alpha-methyldopamine) were found after the administration of both single-doses and maintenance-doses of AMPT.<span class="mw-ref" id="cite_ref-engelman_1968_5-2"><a href="#cite_note-engelman_1968-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>  Small amounts of methyltyramine and alpha-methylnoradrenaline were found in patients undergoing AMPT therapy.<span class="mw-ref" id="cite_ref-engelman_1968_5-3"><a href="#cite_note-engelman_1968-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>  Urine analysis also recovered 45 to 88 percent of unchanged AMPT after drug ingestion.<span class="mw-ref" id="cite_ref-brogden_4-9"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Of the total AMPT excreted, 50 to 60 percent appeared in urine within the first 8 hours and 80 to 90 percent appeared within 24 hours of oral administration.<span class="mw-ref" id="cite_ref-brogden_4-10"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_Use">Medical Use</h2></summary>
    
<p><i><b>Pheochromocytoma</b></i></p>

<p>Pheochromocytoma is a rare neuroendocrine tumor that results in the release of too much epinephrine and norepinephrine, hormones that control heart rate, metabolism, and blood pressure.<span class="mw-ref" id="cite_ref-pedia_7-0"><a href="#cite_note-pedia-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span> AMPT was used in the 1960s for preoperative pharmacological control of catecholamine overexpression that causes hypertension and other arterial and cardiac abnormalities.<span class="mw-ref" id="cite_ref-prys_8-0"><a href="#cite_note-prys-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span> The use of AMPT to treat Pheochromocytoma prior to surgery was discontinued due to its extensive side effects.<span class="mw-ref" id="cite_ref-prys_8-1"><a href="#cite_note-prys-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p><i><b>Drug Interactions</b></i></p>

<p><i>Psychosis</i>-
Phosphorylation of tyrosine hydroxylase at Ser31 or Ser40 can increase dopamine biosynthesis; therefore an increase in pSer31 or pSer40 elevates dopamine synthesis in DA neurons.<span class="mw-ref" id="cite_ref-ankenman_2-2"><a href="#cite_note-ankenman-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span>  Excessive dopamine in the mesolimbic pathways of the brain produces psychotic symptoms.<span class="mw-ref" id="cite_ref-nestler_1-2"><a href="#cite_note-nestler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span> Antipsychotic medications block dopamine D2 receptors in the caudate and putamen as well as in limbic target areas, they can also block or partially block serotonin.<span class="mw-ref" id="cite_ref-nestler_1-3"><a href="#cite_note-nestler-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span>  Therapy with AMPT could prove to be more specific to dopamine and therefore eliminate some of the negative side effects of antipsychotic drugs.</p>

<p><i>Cocaine and Methamphetamines</i>-
The dopamine transporter (DAT) is a principal site of action for cocaine. Cocaine inhibits DAT function and vesicular dopamine transport (VMAT).<span class="mw-ref" id="cite_ref-brown_9-0"><a href="#cite_note-brown-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> Cocaine administration abruptly and reversibly increases both the Vmax of dopamine uptake and the Bmax of vesicular monoamine transporter 2 (VMAT-2) ligand (dihydrotetrabenazine) binding.<span class="mw-ref" id="cite_ref-brown_9-1"><a href="#cite_note-brown-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>  Dopamine depletion resulting from administration of AMPT had similar neuropharmacological effects as cocaine.<span class="mw-ref" id="cite_ref-brown_9-2"><a href="#cite_note-brown-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>  Administration of methamphetamine, a dopamine-releasing agent, rapidly decreased vesicular uptake.<span class="mw-ref" id="cite_ref-brown_9-3"><a href="#cite_note-brown-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>  A relationship between cytoplasmic dopamine concentration and VMAT activity was established using cocaine, methamphetamines, and AMPT. Although it is not well understood, this relationship allows for AMPT’s inhibitory property, which blocks tyrosine hydroxylase, to increase dopamine transport by the vesicle monoamine transporter-2.<span class="mw-ref" id="cite_ref-brown_9-4"><a href="#cite_note-brown-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span> This leads to a reduction in the newly synthesized pool of dopamine from replenished tyrosine.<span class="mw-ref" id="cite_ref-thomas_10-0"><a href="#cite_note-thomas-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> AMPT’s effect on dopamine concentration and transport is reversible and short-lived. If methamphetamine is administered while cytoplasmic dopamine is depleted to about 50% of the control levels, its neurotoxic effects are averted (Thomas et al., 2008).  The recovery of dopamine to normal levels after AMPT administration takes about 2 to 7 days, and this repletion of dopamine is not changed by methamphetamine.<span class="mw-ref" id="cite_ref-thomas_10-1"><a href="#cite_note-thomas-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span>  For these reasons AMPT seems to be a better treatment drug in methamphetamine addicts than reserpine, which is also being researched as a possible methamphetamine treatment drug. Reserpine causes almost full loss of dopamine from the striatum by disrupting vesicle storage. The repletion of dopamine after reserpine administration is slower than AMPT.<span class="mw-ref" id="cite_ref-thomas_10-2"><a href="#cite_note-thomas-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span>  Additionally, administration of reserpine when dopamine is maximally depleted causes neurotoxic effects, which does not occur with AMPT treatment.<span class="mw-ref" id="cite_ref-thomas_10-3"><a href="#cite_note-thomas-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> AMPT’s role in addiction has also been studied via changes in dopamine binding to D2 and D3 receptors in the striatum (caudate, putamen, and ventral striatum) after the administration of AMPT.<span class="mw-ref" id="cite_ref-martinez_11-0"><a href="#cite_note-martinez-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Findings revealed that cocaine-dependent subjects exhibited lower levels of endogenous dopamine relative to healthy subjects after AMPT administration. Similar positive effects were found in the role of AMPT in methamphetamine-addicted subjects.</p>

<p><i>Dystonia and Dyskinesia</i>-
Dystonias and dyskinesias onset seems to derive from inconsistent regulation of dopamine in dopamine pathways.<span class="mw-ref" id="cite_ref-ankenman_2-3"><a href="#cite_note-ankenman-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span> AMPT’s ability to deplete dopamine in the CNS makes it a promising target for treatment of dopamine related disorders.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Side-effects">Side-effects</h2></summary>
    
<p>AMPT administration in healthy subjects has shown to cause increased sleepiness, decreased calmness, increased tension and anger, and a trend for increased depression.<span class="mw-ref" id="cite_ref-brogden_4-11"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Sedation was also reported as a side effect of AMPT ingestion. However, sedation was not seen in AMPT doses of less than 2g per day.<span class="mw-ref" id="cite_ref-engelman_6-5"><a href="#cite_note-engelman-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Patients have reported insomnia as a withdrawal symptom post AMPT exposure.<span class="mw-ref" id="cite_ref-engelman_1968_5-4"><a href="#cite_note-engelman_1968-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span>  When L-dopa is administered following AMPT administration, the effects of AMPT are reversed.<span class="mw-ref" id="cite_ref-mccann_12-0"><a href="#cite_note-mccann-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span> These findings suggest that AMPT's effect on alertness and anxiety is catecholamine-specific and further supports that catecholamines are involved in the regulation of normal states of arousal and pathological anxiety symptoms.<span class="mw-ref" id="cite_ref-mccann_12-1"><a href="#cite_note-mccann-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span>  Patients have reported hand, leg, and trunk tremors as well as tightening of the jaw post AMPT drug therapy. These Parkinson like side effects are supported by the lack of dopamine in the brain as in Parkinson’s patients.<span class="mw-ref" id="cite_ref-brogden_4-12"><a href="#cite_note-brogden-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> Tourette syndrome patients treated with AMPT developed akinesia, akathisia, and oculogyric crisis.<span class="mw-ref" id="cite_ref-sweet_13-0"><a href="#cite_note-sweet-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> Most severe of all, patients developed crystalluria (crystals in the urine) after undergoing AMPT drug treatments.<span class="mw-ref" id="cite_ref-sweet_13-1"><a href="#cite_note-sweet-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span></p>

<p>Prolonged administration can have an impact upon the circadian rhythm.<span class="mw-ref" id="cite_ref-pmid11390253_14-0"><a href="#cite_note-pmid11390253-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Mechanism">Mechanism</h2></summary>
    
<p>As a competitive inhibitor of tyrosine hydroxylase,  it prevents the conversion of <a href="Tyrosine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tyrosine" title="Tyrosine">tyrosine</a> to <a href="L-DOPA.htm" tppabs="https://ptable.com/wiki/compounds/A/L-DOPA" title="L-DOPA">L-DOPA</a>, the precursor to <a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>. This results in lowered systematic catecholamine (<a href="Dopamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Dopamine" title="Dopamine">dopamine</a>, <a href="Epinephrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Epinephrine" title="Epinephrine" class="mw-redirect">epinephrine</a> and norepinephrine) levels.</p>

<center><div class="thumb tnone"></div><div class="thumbinner" style="width:222px"><img src="../I/m/Catecholamines_biosynthesis.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Catecholamines_biosynthesis.svg.png" data-file-width="676" data-file-height="1536" data-file-type="drawing" height="500" width="220"><div class="thumbcaption" style="text-align: left">Biosynthesis of dopamine: Dopamine, norepinephrine, and epinephrine are all synthesized through a multistep processing of tyrosine. Tyrosine is a highly concentrated amino acid in catecholaminergic neurons</div></div></center>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist columns references-column-width" style="-moz-column-width: 30em; -webkit-column-width: 30em; column-width: 30em; list-style-type: decimal;">
<ol class="mw-references references"><li id="cite_note-nestler-1"> <span id="mw-reference-text-cite_note-nestler-1" class="mw-reference-text"><cite id="CITEREFNestlerHymanMalenka2008" class="citation book cs1">Nestler, Eric J.; Hyman, Steven E.; Malenka, Robert C. (2008). <a href="javascript:if(confirm('https://books.google.com/?id=YYUMZDeQNV4C&printsec=frontcover&dq=Molecular+Neuropharmacology:+A+Foundation+for+Clinical+Neuroscience  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://books.google.com/?id=YYUMZDeQNV4C&printsec=frontcover&dq=Molecular+Neuropharmacology:+A+Foundation+for+Clinical+Neuroscience#v=onepage&q=Molecular%20Neuropharmacology:%20A%20Foundation%20for%20Clinical%20Neuroscience&f=false'" tppabs="https://books.google.com/?id=YYUMZDeQNV4C&printsec=frontcover&dq=Molecular+Neuropharmacology:+A+Foundation+for+Clinical+Neuroscience#v=onepage&q=Molecular%20Neuropharmacology:%20A%20Foundation%20for%20Clinical%20Neuroscience&f=false" class="external text external"><i>Molecular Neuropharmacology: A Foundation for Clinical Neuroscience, Second Edition</i></a>. McGraw Hill Professional. ISBN<span>&nbsp;</span><bdi>9780071641197</bdi>.</cite></span></li><li id="cite_note-ankenman-2"> <span id="mw-reference-text-cite_note-ankenman-2" class="mw-reference-text"><cite id="CITEREFAnkenmanSalvatore2007" class="citation journal cs1">Ankenman, Ralph; Salvatore, Michael F. (2007). "Low Dose Alpha-Methyl-Para-Tyrosine (AMPT) in the Treatment of Dystonia and Dyskinesia". <i>The Journal of Neuropsychiatry and Clinical Neurosciences</i>. <b>19</b> (1): 65–69. doi:<a href="javascript:if(confirm('https://doi.org/10.1176%2Fjnp.2007.19.1.65  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1176%2Fjnp.2007.19.1.65'" tppabs="https://doi.org/10.1176%2Fjnp.2007.19.1.65" class="external text external">10.1176/jnp.2007.19.1.65</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0895-0172  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0895-0172'" tppabs="https://www.worldcat.org/issn/0895-0172" class="external text external">0895-0172</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17308229  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17308229'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17308229" class="external text external">17308229</a>.</cite></span></li><li id="cite_note-3"> <span id="mw-reference-text-cite_note-3" class="mw-reference-text"><cite id="CITEREFDrago2002" class="citation cs2">Drago, Filippo (2002), <a href="javascript:if(confirm('http://www.google.com/patents/US6359001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.google.com/patents/US6359001'" tppabs="http://www.google.com/patents/US6359001" class="external text external"><i>Use of α-methyl-</i>p<i>-tyrosine to inhibit melanin production in iris melanocytes</i></a><span class="reference-accessdate">, retrieved <span class="nowrap">November 6,</span> 2016</span></cite></span></li><li id="cite_note-brogden-4"> <span id="mw-reference-text-cite_note-brogden-4" class="mw-reference-text"><cite id="CITEREFBrogdenHeelSpeightAvery1981" class="citation journal cs1">Brogden, R. N.; Heel, R. C.; Speight, T. M.; Avery, G. S. (1981). "alpha-Methyl-p-tyrosine: a review of its pharmacology and clinical use". <i>Drugs</i>. <b>21</b> (2): 81–89. doi:<a href="javascript:if(confirm('https://doi.org/10.2165%2F00003495-198121020-00001  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.2165%2F00003495-198121020-00001'" tppabs="https://doi.org/10.2165%2F00003495-198121020-00001" class="external text external">10.2165/00003495-198121020-00001</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0012-6667  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0012-6667'" tppabs="https://www.worldcat.org/issn/0012-6667" class="external text external">0012-6667</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/7009139  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/7009139'" tppabs="https://pubmed.ncbi.nlm.nih.gov/7009139" class="external text external">7009139</a>.</cite></span></li><li id="cite_note-engelman_1968-5"> <span id="mw-reference-text-cite_note-engelman_1968-5" class="mw-reference-text"><cite id="CITEREFEngelmanHorwitzJéquierSjoerdsma1968" class="citation journal cs1">Engelman, Karl; Horwitz, David; Jéquier, Eric; Sjoerdsma, Albert (1968). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297204'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297204" class="external text external">"Biochemical and pharmacologic effects of α-methyltyrosine in man"</a>. <i>Journal of Clinical Investigation</i>. <b>47</b> (3): 577–594. doi:<a href="javascript:if(confirm('https://doi.org/10.1172%2FJCI105754  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1172%2FJCI105754'" tppabs="https://doi.org/10.1172%2FJCI105754" class="external text external">10.1172/JCI105754</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0021-9738  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0021-9738'" tppabs="https://www.worldcat.org/issn/0021-9738" class="external text external">0021-9738</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297204  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297204'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC297204" class="external text external">297204</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/5637145  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/5637145'" tppabs="https://pubmed.ncbi.nlm.nih.gov/5637145" class="external text external">5637145</a>.</cite></span></li><li id="cite_note-engelman-6"> <span id="mw-reference-text-cite_note-engelman-6" class="mw-reference-text"><cite id="CITEREFEngelmanSjoerdsma1966" class="citation journal cs1">Engelman, K; Sjoerdsma, A (1966). "Inhibition of Catecholamine Biosynthesis in Man". <i>Circulation Research</i>. <b>18</b> (S6): I–104–I–109. doi:<a href="javascript:if(confirm('https://doi.org/10.1161%2F01.RES.18.S6.I-104  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1161%2F01.RES.18.S6.I-104'" tppabs="https://doi.org/10.1161%2F01.RES.18.S6.I-104" class="external text external">10.1161/01.RES.18.S6.I-104</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0009-7330  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0009-7330'" tppabs="https://www.worldcat.org/issn/0009-7330" class="external text external">0009-7330</a>.</cite></span></li><li id="cite_note-pedia-7"> <span id="mw-reference-text-cite_note-pedia-7" class="mw-reference-text">[Encyclopedia, A.D.A.M. "Causes, Incidence, and Risk Factors." Pheochromocytoma. U.S. National Library of Medicine, 18 Nov. 0000. Web. 11 May 2012.].</span></li><li id="cite_note-prys-8"> <span id="mw-reference-text-cite_note-prys-8" class="mw-reference-text"><cite id="CITEREFPrys‐Roberts2000" class="citation journal cs1">Prys‐Roberts, C. (2000). <a href="javascript:if(confirm('http://bja.oxfordjournals.org/content/85/1/44  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://bja.oxfordjournals.org/content/85/1/44'" tppabs="http://bja.oxfordjournals.org/content/85/1/44" class="external text external">"Phaeochromocytoma—recent progress in its management"</a>. <i>British Journal of Anaesthesia</i>. <b>85</b> (1): 44–57. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1093%2Fbja%2F85.1.44  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1093%2Fbja%2F85.1.44'" tppabs="https://doi.org/10.1093%2Fbja%2F85.1.44" class="external text external">10.1093/bja/85.1.44</a></span>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0007-0912  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0007-0912'" tppabs="https://www.worldcat.org/issn/0007-0912" class="external text external">0007-0912</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/10927994  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/10927994'" tppabs="https://pubmed.ncbi.nlm.nih.gov/10927994" class="external text external">10927994</a>.</cite></span></li><li id="cite_note-brown-9"> <span id="mw-reference-text-cite_note-brown-9" class="mw-reference-text"><cite id="CITEREFBrownHansonFleckenstein2001" class="citation journal cs1">Brown, Jeffrey M.; Hanson, Glen R.; Fleckenstein, Annette E. (2001). <a href="javascript:if(confirm('http://jpet.aspetjournals.org/content/296/3/762  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jpet.aspetjournals.org/content/296/3/762'" tppabs="http://jpet.aspetjournals.org/content/296/3/762" class="external text external">"Regulation of the Vesicular Monoamine Transporter-2: A Novel Mechanism for Cocaine and Other Psychostimulants"</a>. <i>Journal of Pharmacology and Experimental Therapeutics</i>. <b>296</b> (3): 762–767. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0022-3565  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0022-3565'" tppabs="https://www.worldcat.org/issn/0022-3565" class="external text external">0022-3565</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11181904  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11181904'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11181904" class="external text external">11181904</a>.</cite></span></li><li id="cite_note-thomas-10"> <span id="mw-reference-text-cite_note-thomas-10" class="mw-reference-text"><cite id="CITEREFThomasFrancescutti-VerbeemKuhn2016" class="citation journal cs1">Thomas, David M.; Francescutti-Verbeem, Dina M.; Kuhn, Donald M. (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668123'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668123" class="external text external">"The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity"</a>. <i>Journal of Neurochemistry</i>. <b>105</b> (3): 605–616. doi:<a href="javascript:if(confirm('https://doi.org/10.1111%2Fj.1471-4159.2007.05155.x  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fj.1471-4159.2007.05155.x'" tppabs="https://doi.org/10.1111%2Fj.1471-4159.2007.05155.x" class="external text external">10.1111/j.1471-4159.2007.05155.x</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0022-3042  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0022-3042'" tppabs="https://www.worldcat.org/issn/0022-3042" class="external text external">0022-3042</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668123  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668123'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2668123" class="external text external">2668123</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18088364  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18088364'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18088364" class="external text external">18088364</a>.</cite></span></li><li id="cite_note-martinez-11"> <span id="mw-reference-text-cite_note-martinez-11" class="mw-reference-text"><cite id="CITEREFMartinezGreeneBroftKumar2016" class="citation journal cs1">Martinez, Diana; Greene, Kaitlin; Broft, Allegra; Kumar, Dileep; Liu, Fei; Narendran, Rajesh; Slifstein, Mark; Van Heertum, Ronald; Kleber, Herbert D. (2016). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875882  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875882'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875882" class="external text external">"Lower Level of Endogenous Dopamine in Patients With Cocaine Dependence: Findings From PET Imaging of D2/D3 Receptors Following Acute Dopamine Depletion"</a>. <i>The American Journal of Psychiatry</i>. <b>166</b> (10): 1170–1177. doi:<a href="javascript:if(confirm('https://doi.org/10.1176%2Fappi.ajp.2009.08121801  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1176%2Fappi.ajp.2009.08121801'" tppabs="https://doi.org/10.1176%2Fappi.ajp.2009.08121801" class="external text external">10.1176/appi.ajp.2009.08121801</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0002-953X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0002-953X'" tppabs="https://www.worldcat.org/issn/0002-953X" class="external text external">0002-953X</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875882  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875882'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875882" class="external text external">2875882</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19723785  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19723785'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19723785" class="external text external">19723785</a>.</cite></span></li><li id="cite_note-mccann-12"> <span id="mw-reference-text-cite_note-mccann-12" class="mw-reference-text"><cite id="CITEREFMcCannThorneHallPopp1995" class="citation journal cs1">McCann, Una D.; Thorne, David; Hall, Martica; Popp, Kathy; Avery, Warren; Sing, Helen; Thomas, Maria; Belenky, Gregory (1995). <a href="javascript:if(confirm('https://zenodo.org/record/1258625/files/article.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://zenodo.org/record/1258625/files/article.pdf'" tppabs="https://zenodo.org/record/1258625/files/article.pdf" class="external text external">"The Effects of L-Dihydroxyphenylalanine on Alertness and Mood in α-Methyl-Para-Tyrosine-Treated Healthy Humans"</a> <span class="cs1-format">(PDF)</span>. <i>Neuropsychopharmacology</i>. <b>13</b> (1): 41–52. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2F0893-133X%2894%2900134-L  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2F0893-133X%2894%2900134-L'" tppabs="https://doi.org/10.1016%2F0893-133X%2894%2900134-L" class="external text external">10.1016/0893-133X(94)00134-L</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0893-133X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0893-133X'" tppabs="https://www.worldcat.org/issn/0893-133X" class="external text external">0893-133X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/8526970  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/8526970'" tppabs="https://pubmed.ncbi.nlm.nih.gov/8526970" class="external text external">8526970</a>.</cite></span></li><li id="cite_note-sweet-13"> <span id="mw-reference-text-cite_note-sweet-13" class="mw-reference-text"><cite id="CITEREFSweetBruunShapiroShapiro1974" class="citation journal cs1">Sweet, Richard D.; Bruun, Ruth; Shapiro, Elaine; Shapiro, Arthur K. (1974). <a href="javascript:if(confirm('http://jamanetwork.com/journals/jamapsychiatry/article-abstract/491287  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://jamanetwork.com/journals/jamapsychiatry/article-abstract/491287'" tppabs="http://jamanetwork.com/journals/jamapsychiatry/article-abstract/491287" class="external text external">"Presynaptic Catecholamine Antagonists as Treatment for Tourette Syndrome: Effects of Alpha Methyl Para Tyrosine and Tetrabenazine"</a>. <i>Archives of General Psychiatry</i>. <b>31</b> (6): 857–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1001%2Farchpsyc.1974.01760180095012  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1001%2Farchpsyc.1974.01760180095012'" tppabs="https://doi.org/10.1001%2Farchpsyc.1974.01760180095012" class="external text external">10.1001/archpsyc.1974.01760180095012</a>. ISSN<span>&nbsp;</span><a href="javascript:if(confirm('https://www.worldcat.org/issn/0003-990X  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.worldcat.org/issn/0003-990X'" tppabs="https://www.worldcat.org/issn/0003-990X" class="external text external">0003-990X</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/4613321  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/4613321'" tppabs="https://pubmed.ncbi.nlm.nih.gov/4613321" class="external text external">4613321</a>.</cite></span></li><li id="cite_note-pmid11390253-14"> <span id="mw-reference-text-cite_note-pmid11390253-14" class="mw-reference-text"><cite id="CITEREFZimmermannKrahnKleeDitkoff2001" class="citation journal cs1">Zimmermann RC, Krahn LE, Klee GG, Ditkoff EC, Ory SJ, Sauer MV (2001). "Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion". <i>J. Soc. Gynecol. Investig</i>. <b>8</b> (3): 174–178. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1071-5576%2801%2900104-6  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1071-5576%2801%2900104-6'" tppabs="https://doi.org/10.1016%2FS1071-5576%2801%2900104-6" class="external text external">10.1016/S1071-5576(01)00104-6</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/11390253  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/11390253'" tppabs="https://pubmed.ncbi.nlm.nih.gov/11390253" class="external text external">11390253</a>.</cite></span></li></ol></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><a href="javascript:if(confirm('http://www.clinicaltrials.gov/ct/show/NCT00082030?order=10  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.clinicaltrials.gov/ct/show/NCT00082030?order=10'" tppabs="http://www.clinicaltrials.gov/ct/show/NCT00082030?order=10" class="external autonumber external"></a> and <a href="javascript:if(confirm('http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2004-M-0160.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2004-M-0160.html'" tppabs="http://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_2004-M-0160.html" class="external autonumber external"></a> A Clinical Trial</li></ul>

<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>